Leena Pitkänen
Kliininen opettaja
Lääketieteen laitos, Kliinisen lääketieteen yksikkö
leena.pitkanen@uef.fi | 447179380
Julkaisut
11 kappaletta-
Tarvittaisiinko Suomessakin rajoitettua ajo-oikeutta?
Martikainen, Oona; Piironen, Samu; Pitkänen, Leena . 2022. Lääkärilehti. 77: 292 -
The effect of different sources of fish and camelina sativa oil on immune cell and adipose tissue mRNA expression in subjects with abnormal fasting glucose metabolism: a randomized controlled trial
de Mello, VD; Dahlman, I; Lankinen, M; Kurl, S; Pitkänen, L; Laaksonen, DE; Schwab, US; Erkkilä, AT. 2019. Nutrition and diabetes. 9: 1 -
Näkökyky ja ajaminen
Pitkänen, Leena. 2018. Yleislääkäri. 33: 9-11 -
Frequency of IOP measurements and eye check-ups in elderly Finns
Vesti E, Nevalainen T, Jaatinen J, Pitkänen L. 2016. Acta ophthalmologica. [Epub ahead of print 22 Nov 2016]: 1 -
Retinal arterial macroaneurysms
Pitkänen L, Tommila P, Kaarniranta K, Jääskeläinen JE, Kinnunen K. 2013. Acta ophthalmologica. 2013: 1-4 -
Binding of betaxolol, metoprolol and oligonucleotides to synthetic and bovine ocular melanin, and prediction of drug binding to melanin in human choroid-retinal pigment epithelium
Pitkänen L, Ranta V-P, Moilanen H, Urtti A. 2007. Pharmaceutical research. 24: 2063-2070 -
Retinal Pigment Epithelium as a Barrier in Drug Permeation and as a Target of Non-Viral Gene Delivery
Pitkänen L. 2007. Kuopio University Publications D. Medical Sciences -
Permeability of retinal pigment epithelium: Effects of permeant molecular weight and lipophilicity
Pitkänen L, Ranta V-P, Moilanen H, Urtti A. 2005. Investigative ophthalmology and visual science. 46: 641-646 -
Neural retina limits the nonviral gene transfer to retinal pigment epithelium in an vitro bovine eye model
Pitkänen L, Pelkonen J, Ruponen M, Rönkkö S, Urtti A. 2004. AAPS journal. 6: 1-9 -
Retinal disease models for development of drug and gene therapies
Pitkänen L, Salminen L, Urtti A. Teoksessa: Mitra AK(toim.) , 2003. Ophthalmic Drug Delivery Systems. s. 515-533. Marcel Dekker